These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of in vitro assays for neoplastic transformation and tumor promotion. Rosa S, Bignami M. Ann Ist Super Sanita; 1989; 25(4):545-8. PubMed ID: 2631620 [Abstract] [Full Text] [Related]
3. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors. Blondel B, Talbot N, Merlo GR, Wychowski C, Yokozaki H, Valverius EM, Salomon DS, Bassin RH. Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293 [Abstract] [Full Text] [Related]
5. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes. Vennström B, Bravo R. Oncogene; 1987 Jun; 1(3):271-6. PubMed ID: 3330775 [Abstract] [Full Text] [Related]
9. Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions. Martin W, Zempel G, Hülser D, Willecke K. Cancer Res; 1991 Oct 01; 51(19):5348-51. PubMed ID: 1913656 [Abstract] [Full Text] [Related]
10. Cooperation of oncogenes in the multistep transformation of established fibroblasts in culture. Davenport EA, Drobes BL, Menke SL, Vaidya TB, Taparowsky EJ. Anticancer Res; 1988 Oct 01; 8(5A):959-69. PubMed ID: 2845855 [Abstract] [Full Text] [Related]
12. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts. Zerlin M, Julius MA, Cerni C, Marcu KB. Oncogene; 1987 Mar 01; 1(1):19-27. PubMed ID: 3325875 [Abstract] [Full Text] [Related]
13. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes. Denner J, Jandrig B, Spitkovsky DD, Ehm I, Kisselyov FL, Schramm T. Neoplasma; 1988 Mar 01; 35(3):263-70. PubMed ID: 3405335 [Abstract] [Full Text] [Related]
15. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2. Choe C, Chen N, Sawadogo M. Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720 [Abstract] [Full Text] [Related]
16. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Koskinen PJ, Ayer DE, Eisenman RN. Cell Growth Differ; 1995 Jun 01; 6(6):623-9. PubMed ID: 7669717 [Abstract] [Full Text] [Related]
17. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line. Colletta G, Cirafici AM, Consiglio E, Vecchio G. Oncogene Res; 1987 Jun 01; 1(4):459-66. PubMed ID: 3329719 [Abstract] [Full Text] [Related]
18. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines. Voskas D, Mader R, Lee J, Hurta RA. Biochem Cell Biol; 2001 Jun 01; 79(1):69-81. PubMed ID: 11235918 [Abstract] [Full Text] [Related]
19. Morphological alteration of X-ray induced partially transformed human cells by transfection with a small c-myc DNA sequence. Kano Y, Nohno T, Takahashi R, Hiragami F, Kawamura K, Strebhardt K, Namba M, Sugiyama T, Little JB. Biochem Biophys Res Commun; 2000 Jun 16; 272(3):887-94. PubMed ID: 10860847 [Abstract] [Full Text] [Related]
20. Preneoplastic potential of morphologically distinct transformed foci induced by 3-methylcholanthrene. Keshava N, Keshava C, Whong WZ, Hubbs AF, Nath J, Ong T. Environ Mol Mutagen; 1998 Jun 16; 32(4):369-76. PubMed ID: 9882012 [Abstract] [Full Text] [Related] Page: [Next] [New Search]